← Leaderboards
Rany Condos
New York University School Of Medicine
$1,360,254
Attributed
$2,623,265
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $853.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,623,265 · 11
By mechanism
R01$2,526,022 · 1
M01$97,243 · 10
Top collaborators
- Steven B Abramson3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Leopoldo Nicolas Segal$9,785,416
- Steven B Abramson$15,320,758
- John A Dodson$11,071,981
- Lorna Thorpe$21,064,292
- Leeor Alon$960,293
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisHuman SubjectClinical ResearchInterferon GammaDiagnostic Respiratory LavageCytokineQuestionnairesMycobacterium TuberculosisInterleukin 5Interleukin 2ImmunocytochemistryInterleukin 4Research PersonnelResourcesPatient Oriented ResearchSourceInstitutionIdiopathic Pulmonary FibrosisHuman Therapy EvaluationImmune ResponseFundingGrantBactericidal ImmunityComputer Retrieval Of Information On Scientific Projects Database
Grant awards (21)
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$841,864
R01 · FY2025 · HL
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$830,331
R01 · FY2024 · HL
Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2$853,827
R01 · FY2023 · HL
CLINICAL TRIAL: AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBRO$4,468
M01 · FY2008 · RR · contact PI
TUBERCULOSIS RESEARCH BLOOD BANK$258
M01 · FY2008 · RR · contact PI
TUBERCULOSIS RESEARCH BLOOD BANK$2,269
M01 · FY2007 · RR · contact PI
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$394
M01 · FY2007 · RR · contact PI
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$934
M01 · FY2006 · RR · contact PI
MOXIFLOXACIN DURING THE FIRST 2 MONTHS OF TREATMENT FOR PULMONARY TUBERCULOSIS$21,962
M01 · FY2005 · RR
AEROSOL INTERFERON-GAMMA TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)$955
M01 · FY2005 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$477
M01 · FY2005 · RR
Aerosol Interferon-gamma Treatment in Idiopathic Pulmonary Fibrosis (IPF)$18,038
M01 · FY2004 · RR
MOXIFLOXACIN DURING THE FIRST 2 MONTHS OF TREATMENT FOR PULMONARY TUBERCULOSIS$15,240
M01 · FY2004 · RR
Lung Cytokine Levels in Tuberculosis Infection$8,968
M01 · FY2004 · RR
Volatile Markers of Pulmonary Tuberculosis in the Breath$2,274
M01 · FY2004 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2002 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2001 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$21,006
M01 · FY2000 · RR
LUNG CYTOKINE LEVELS IN TUBERCULOSIS INFECTION$0
M01 · FY2000 · RR
AEROSOL INTERFERON GAMMA TREATMENT IN TUBERCULOSIS/AIDS$0
M01 · FY2000 · RR
AEROSOL INTERFERON GAMMA TREATMENT IN TUBERCULOSIS/AIDS$0
M01 · FY2000 · RR